2nd Quarter - Report
W STRATEGIES, LLC for ABBOTT LABORATORIES
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
CY 2021 DMEPOS rule as it relates to continuous glucose monitors.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Health Issues HCR
H.R. 4128: VALID Act of 2021. Education related to COVID-19 testing and implementation of FY 2021 Consolidated Appropriations Act. 21st Century Cures 2.0. Issues related to adult malnutrition. Legislation related to medical device shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.